Trading of Beximco Pharmaceuticals’ Global Depository Receipts (GDRs) officially resumed on the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) on Friday (June 26), following the withdrawal of a nearly six-month-old trading suspension.
The development is expected to bolster the international credibility of Bangladesh’s capital market and restore the confidence of foreign investors, according to the DSE Brokers Association of Bangladesh (DBA). The DBA shared the update through a press release issued on Saturday (June 27).
The Origin of the Suspension
Trading of Beximco Pharma’s GDRs had been suspended since January 2 of this year. The suspension was triggered by the company’s failure to publish its audited financial statements for the fiscal year ending June 30, 2025, as well as subsequent financial reports, within the mandatory timeframe.
Under the LSE rules, any listing suspended for more than six months faces the risk of automatic delisting. To protect foreign institutional and individual investors from the fallout of a potential delisting, the DBA had reached out to the Chairman of the Bangladesh Securities and Exchange Commission (BSEC) urging immediate intervention.
Inter-Agency Coordination Resolves the Crisis
The resolution came after coordinated efforts led by DBA President Saiful Islam, who facilitated communication between the BSEC and the top management of Beximco Pharmaceuticals.
Following these discussions, the BSEC permitted the company to hold a special board meeting. During the meeting, Beximco Pharma approved and published its audited annual financial statements for the 2024-25 fiscal year, along with the first, second, and third quarterly financial reports for the 2025-26 fiscal year. With the reporting backlog cleared, the London Stock Exchange subsequently lifted the trading ban.
Boosting Foreign Investor Confidence
The DBA emphasized that this timely resolution will significantly strengthen Bangladesh’s regulatory image on the global stage.
“This decision will reinforce the international acceptability and image of the Bangladeshi stock market, playing a highly positive role in boosting foreign investor confidence,” the DBA statement noted.
The association expressed optimism that the government will continue to pursue investor-friendly policies, necessary structural reforms, and timely interventions to attract foreign direct and portfolio investment, thereby solidifying Bangladesh’s position in global markets.
Expressions of Gratitude
The DBA extended its gratitude to several key officials who played pivotal roles in resolving the crisis, including:
-
Finance and Planning Minister Amir Khosru Mahmud Chowdhury
-
Tanvir Ghani, Special Assistant to the Prime Minister on Investment and Stock Market Affairs
-
BSEC Chairman Masud Khan and commission officials
-
The Board of Directors and management of Beximco Pharmaceuticals, as well as the media for their continuous support.
